E Fund Management (HK)’s Gilead Sciences GILD Stock Holding History

E Fund Management (HK)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$896K	Buy	7,092 +2,394	+51%	+$315K	0.3%	58
2026 Q1	$655K	Buy	4,698 +687	+17%	+$96.2K	0.3%	54
2025 Q4	$573K	Buy	4,011 +2,894	+259%	+$352K	0.19%	60
2025 Q3	$124K	Buy	1,117 +533	+91%	+$60.6K	0.08%	75
2025 Q2	$64.7K	Hold	584	–	–	0.06%	79
2025 Q1	$65K	Buy	584 +484	+484%	+$49.9K	0.06%	81
2024 Q4	$9K	Buy	100 +91	+1,011%	+$8.19K	0.01%	104
2024 Q3	$1K	Hold	9	–	–	﹤0.01%	116
2024 Q2	$1K	Buy	+9	New	+$601	﹤0.01%	93

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

E Fund Management (HK)'s GILD Position: Q2 2026 in Review

E Fund Management (HK) increased its Gilead Sciences (GILD) stake by 51% in Q2 2026, buying an estimated $315K and bringing the position to 7,092 shares worth $896K. The position accounts for 0.3% of the portfolio, ranked #58.

E Fund Management (HK) first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

E Fund Management (HK) held 7,092 shares of Gilead Sciences worth $896K as of Q2 2026.
E Fund Management (HK) bought 2,394 Gilead Sciences shares in Q2 2026, an estimated $315K.
Gilead Sciences made up 0.3% of E Fund Management (HK)'s portfolio in Q2 2026, its #58 holding.
E Fund Management (HK) first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.